These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 12003897)

  • 1. Breast screening guidelines should be adapted in Down's syndrome.
    Satgé D; Sasco AJ
    BMJ; 2002 May; 324(7346):1155. PubMed ID: 12003897
    [No Abstract]   [Full Text] [Related]  

  • 2. [Update on current care guidelines: appropriate treatment of medical problems associated with Down's syndrome].
    ; ; Kaski M; Aaltonen S; Heiskala H; Hyvärinen L; Komulainen J; Määttä T; Noponen AL; Verkasalo M; Wilska M; Ala-Mello S; Hiiri A; Sakki A
    Duodecim; 2011; 127(4):364-5. PubMed ID: 21442856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of the relationship between Down's syndrome and hearing loss.
    Kattan HA; Jarrar RF; Mahasin ZZ
    Saudi Med J; 2000 Oct; 21(10):931-3. PubMed ID: 11369955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast imaging screening status and updates.
    Mizuguchi S; Roland L
    J Ky Med Assoc; 2009 Oct; 107(10):397-400. PubMed ID: 19873797
    [No Abstract]   [Full Text] [Related]  

  • 5. Interference in the autoDELFIA(R) hAFP immunoassay and effect on second-trimester Down's syndrome screening.
    Mannings L; Trow S; Newman J; Nix B; Evans C
    Ann Clin Biochem; 2011 Sep; 48(Pt 5):438-40. PubMed ID: 21795408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adults with Down's syndrome: the prevalence of complications and health care in the community.
    Henderson A; Lynch SA; Wilkinson S; Hunter M
    Br J Gen Pract; 2007 Jan; 57(534):50-5. PubMed ID: 17244425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening for breast cancer in women 40-49 years of age].
    Riv Inferm; 1997; 16(3):172-7. PubMed ID: 9460467
    [No Abstract]   [Full Text] [Related]  

  • 8. Antenatal screening for Down's syndrome.
    Smith L
    Mod Midwife; 1995 Jun; 5(6):23-6. PubMed ID: 7788401
    [No Abstract]   [Full Text] [Related]  

  • 9. Capillary TSH screening programme for Down's syndrome in Scotland, 1997-2009.
    McGowan S; Jones J; Brown A; Reynolds L; Leyland K; Charleton P; Rahim M; Mansor M; Ritha S; Donaldson M;
    Arch Dis Child; 2011 Dec; 96(12):1113-7. PubMed ID: 21965810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer screening recommendations: dynamic extrapolation of limited data.
    Mooney C; Merajver S
    Breast Cancer Res Treat; 2010 May; 121(1):143-6. PubMed ID: 20063195
    [No Abstract]   [Full Text] [Related]  

  • 11. A vision screening of a Down's syndrome population.
    Warshowsky J
    J Am Optom Assoc; 1981 Jul; 52(7):605-7. PubMed ID: 6456298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down's Syndrome screening: confusion or consensus?
    Goldberg JD
    BJOG; 2004 Jun; 111(6):517-8. PubMed ID: 15198776
    [No Abstract]   [Full Text] [Related]  

  • 13. Is breast self-examination an effective screening measure for breast cancer?
    Katschke RW; Schooff M
    J Fam Pract; 2001 Nov; 50(11):994. PubMed ID: 11711022
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for Down's syndrome. Conclusions do not reflect reality.
    Reynolds T
    BMJ; 2002 Jan; 324(7329):111. PubMed ID: 11808522
    [No Abstract]   [Full Text] [Related]  

  • 15. [Down's syndrome risk assessment in Denmark--secondary publication].
    Ekelund CK; Andersen HJ; Christensen J; Ersbak V; Farlie R; Henriques C; Holmskov A; Jensen LN; Jørgensen FS; Hessellund A; Larsen T; Olesen AW; Pedersen OB; Poulsen H; Ramb J; Skibsted L; Skovbo P; Sommer S; Sperling L; Sundberg K; Juul SV; Zingenberg H; Tabor A
    Ugeskr Laeger; 2010 Jun; 172(23):1759-61. PubMed ID: 20552746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Down's syndrome. Modelling does not predict reality accurately.
    Howe D
    BMJ; 2002 Jan; 324(7329):111-2. PubMed ID: 11808523
    [No Abstract]   [Full Text] [Related]  

  • 17. An economic appraisal of alternative pre-natal screening programmes for Down's syndrome.
    Shackley P; McGuire A; Boyd PA; Dennis J; Fitchett M; Kay J; Roche M; Wood P
    J Public Health Med; 1993 Jun; 15(2):175-84. PubMed ID: 7688977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening in women's health, with emphasis on fetal Down's syndrome, breast cancer and osteoporosis.
    Wildschut HI; Peters TJ; Weiner CP
    Hum Reprod Update; 2006; 12(5):499-512. PubMed ID: 16807275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for Down's syndrome. Ratio of femoral length to tibial length needs to be evaluated extensively.
    Sachdev P; Bahl S; Puliyel JM
    BMJ; 2002 Jan; 324(7329):112. PubMed ID: 11808524
    [No Abstract]   [Full Text] [Related]  

  • 20. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.